Featured Video

Interview with the Innovators
Dr Stephen C. Malamud and Dr Susan K. Boolbol discuss the importance of using a clinically validated test such as the Breast Cancer IndexSM (BCI).

Play Videos

Featured Opportunities

  • AVBCC Save the Date
  • View our Special Payers Issue
  • AHDB Subscribe Today
  • Call for Papers
  • Order Reprints

Current Issue

Budgetary Impact of Adding Riociguat to a US Health Plan for the Treatment of Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
Chakkarin Burudpakdee, PharmD, Anshul Shah, MS, Vijay N Joish, PhD, Christine H. Divers, PhD, Avin Yaldo, PhD
December 2014 Vol 7, No 9 - Business
Stakeholder Perspective
Is It Time for Risk-Sharing Contracts In Specialty Pharmacy?
by Atheer A. Kaddis, PharmD
Read More
Diagnosis and Treatment of Bipolar Disorders in Adults: A Review of the Evidence on Pharmacologic Treatments
Michael W Jann, PharmD
December 2014 Vol 7, No 9 - Clinical
Stakeholder Perspective
Bipolar Disorders: Balancing Formulary Management and Clinical Outcomes for a Vulnerable Patient Population
by Gary M. Owens, MD
Read More
Correction
December 2014 Vol 7, No 9
Read More

Supplements

A Multistakeholder Approach to Improving Quality in Rheumatoid Arthritis
Read More
Lowering Costs Through Effective Hematologic Malignancy Diagnosis
Read More
Diagnosis and Management of Polycythemia Vera
Read More
New Directions in the Treatment of Multiple Myeloma: Reports on Carfilzomib Therapy from the 2013 Annual Meeting of the American Society of Hematology
Read More

Editorial

Maintaining Medication Quality
David B. Nash, MD, MBA
December 2014 Vol 7, No 9 - Editorial
I have had the privilege of serving on the Pharmacy and Therapeutics (P&T) committee at Thomas Jefferson University Hospital for nearly a quarter of a century, and I serve as Chair for its Medication Quality subcommittee.
Read More

Your Peers are Reading…

Rewarding Innovation in Drug Development
Emily Saadi, Greg White, MPP
October 2014 Vol 7, No 7 - Perspective
The development of innovative medications is largely a private enterprise that relies chiefly on the investment of pharmaceutical companies in research and development (R&D).
Read More

Upcoming Events

Select Drug Updates

Brintellix (Vortioxetine) Receives FDA Approval for the Treatment of Major Depressive Disorder
Injectafer (Ferric Carboxymaltose Injection) Receives FDA Approval for the Treatment of Iron-Deficiency Anemia
View All Updates

Reader Poll

The main goals of the Affordable Care Act (ACA) are to reduce the number of uninsured Americans, reduce healthcare costs, and improve health outcomes. Assuming it’s too early to measure the impact on health outcomes, is the ACA achieving the other 2 goals?

Submit

  • Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME